D. V. D. Velden

Differential Survival and Therapy Benefit of Patients with Breast Cancer Are Characterized by Distinct Epithelial and Immune Cell Microenvironments

A. Oudenaarden, A. van Oudenaarden, H. Horlings, 2021, Clinical Cancer Research.

Patients With Rare Cancers in the Drug Rediscovery Protocol (DRUP) benefit from Genomics - Guided Treatment Genomics – Guided Treatment of Rare Cancer Patients in DRUP

Henk, E. Cuppen, E. Smit, 2022 .